Hamilton Thorne Ltd.
HTL
Κατάταξη σε μετοχές
#17067
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Τιμή μετοχής
$1.59
Τελευταίος συγχρονισμός: 2024-12-02
Κεφαλαιοποίηση
$245.66M
Αλλαγή (1 ημέρα)
-0.29%
Αλλαγή (1 έτος)
0.22%
Χώρα
US
Εμπόριο Hamilton Thorne Ltd. (HTL)
Κατηγορία
Healthcare
Έσοδα για την Hamilton Thorne Ltd. (HTL)
Έσοδα τον Sep 2024 TTM: $76.72M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Hamilton Thorne Ltd., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $76.72M. Το 2022, η εταιρεία είχε έσοδα $55.87M αύξηση σε σχέση με τα έσοδα του έτους 2021, τα οποία ήταν $52.35M. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την Hamilton Thorne Ltd. από 2008 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $76.72M | 14.13% |
| 2023 | $67.23M | 20.32% |
| 2022 | $55.87M | 6.72% |
| 2021 | $52.35M | 31.61% |
| 2020 | $39.78M | 12.50% |
| 2019 | $35.36M | 21.03% |
| 2018 | $29.21M | 32.06% |
| 2017 | $22.12M | 110.38% |
| 2016 | $10.51M | 16.39% |
| 2015 | $9.03M | 3.75% |
| 2014 | $8.71M | 16.45% |
| 2013 | $7.48M | 18.20% |
| 2012 | $6.33M | -11.64% |
| 2011 | $7.16M | 15.46% |
| 2010 | $6.20M | 29.32% |
| 2009 | $4.79M | 13,987.95% |
| 2008 | $34.03K | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $11.03B | 14,282.21% |
US
|
|
| $34.74B | 45,175.54% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 27,061.50% |
US
|
|
| - | - |
CH
|
